CIK 0001023549
- Non-accelerated filer
XTL BIOPHARMACEUTICALS LTD
Sign in to watch- Ticker
- XTLB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- Incorporated
- Israel
- Entity type
- Other
- Phone
- +972 99557080
- Business address
- XTL BIOPHARMACEUTICALS LTD, C/O ALSTON & BIRD LLP, 90 PARK AVENUE, NEW YORK, NY, 10016
- 4 Open-market buy 10% owner bought 1,300,000 shares at $2.89 ($3,757,000)
- 4 Open-market buy 10% owner bought 1,950,000 shares at an average $2.72 ($5,299,585)
- 4 Open-market buy 10% owner bought 300,000 shares at $2.60 ($778,620)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO bought 15,279 shares at $1.30 ($19,863)
- 4 Open-market buy CEO bought 1,600 shares at $2.98 ($4,768)
- 3 Insider Initial Statement of Ownership
Page 3 of 3 · 49 filings